Towards a “Lyon molecular signature” to individualize the treatment of rectal cancer. Prognostic analysis of a prospective cohort of 94 rectal cancers T1-2-3 Nx MO to be the basis of a molecular signature
| Autor: | Gérard, J.-P., Baulieux, J., Doyen, J., Gal, J., Letouze, E., Olschwang, S., Chapet, O., Romestaing, P. |
|---|---|
| Zdroj: | In Cancer / Radiothérapie December 2012 16(8):688-696 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect